Effect of a Semirigid Foot Insole in Flexible Pes Planus
ConditionFlexible Flatfoot or Pes Planus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorFatma El Zahraa
About this trial
The goal of this clinical trial is to investigate the effect of a semirigid foot insole on radiological angle correction in people with asymptomatic flexible flat feet. The X-ray will be performed while standing barefoot one time and the other while standing on the insole from 2 views.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Asymptomatic people with flexible pes planus. If the pain is greater than 3 out of 10 on the visual analog scale in the last 3 months, the patient is considered to have symptomatic flat feet (Mahdiyar et al., 2021).
Aged 18-35.
BMI max 29.9 kg/cm².
Disqualifiers
Osteoarthritis of the joints of the foot (excluded by x-ray).
Foot Deformities (e.g. Hallux Valgus)
Old fractures of the foot.
Previous injuries to the ankle.
Trial design
Design model
Single group
Treatments tested in this trial
Foot Insole
Other interventionDesigned Semirigid foot insole
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: Semirigid foot insoleExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Radiological foot angles
In the lateral view,the lateral talo-1st metatarsal angle, the calcaneal inclination angle, the angle of Hibbs, the calcaneal-5th metatarsal angle, and the navicular height. In the AP view,The lateral talo-1st metatarsal angle, Talo-2nd metatarsal angle, The talocalcaneal angle, Talonavicular coverage angle and First-fifth metatarsal angle
Time frame
Immediately after the insole insertion. The radiology will be taken one time barefoot and second time with the insole insertion, and the researcher will measure the foot angles pre- and post-insole to measure the correction.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fatma El Zahraa
Lead sponsor
Cairo University
Sponsor institution
Source ClinicalTrials.gov